Crossmark

Overview of FDA’s Expanded Access Program for Investigational Drugs

Crossref DOI link: https://doi.org/10.1177/2168479017694850

Published Online: 2017-12-30

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jarow, Jonathan P.

Lurie, Peter

Ikenberry, Sarah Crowley

Lemery, Steven
License Information

Text and Data Mining valid from 2017-03-01
More Information

Article History

Received: 7 November 2016

Accepted: 26 January 2017

First Online: 30 December 2017